Pages 19 to 21 of todays presentation:
Q1 FY2015 result impacted by
Contraction in total ARS market in Australia in July & August FY2015 with total Patient Treatments in key Monash
markets(1) falling 3.7%
Modest market share contraction in July & August FY2015 in South Australia
Q1 FY2015 result impacted by
Patient Treatment mix shift
Q1 FY2015 volumes from low intervention clinic in Sydney impacted by delayed commissioning and localised
competition
Q1 FY2015 trading conditions impacted Revenue and EBITDA by $3.1 million and $2.6
million respectively
Ann: Annual General Meeting Chairman and CEO presentation., page-5
Add MVF (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.14 |
Change
0.023(2.02%) |
Mkt cap ! $465.6M | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.15 | $1.11 | $1.034M | 923.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 12170 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.14 | 2791 | 4 |
View Market Depth
| Last trade - 15.30pm 19/11/2024 (20 minute delay) ? |
| MVF (ASX) Chart |
